Literature DB >> 1566769

Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance.

R A Wild1, P Alaupovic, I J Parker.   

Abstract

OBJECTIVE: We attempted to evaluate apolipoprotein lipid levels in hirsute hyperandrogenic women and to clarify the influence of insulin resistance versus endogenous sex steroids on these profiles. STUDY
DESIGN: Forty-seven women seen for evaluation of hirsutism in the Reproductive Endocrine Clinic were contrasted with 15 normal women. Thirty-one patients were treated with the gonadotropin-releasing hormone analog, leuprolide acetate, 7.5 mg intramuscularly monthly for 3 months. Insulin resistance was assessed before and after GnRH analog administration. Mean concentrations were compared with the Student t test and analysis of variance.
RESULTS: Hirsute women were heavier and had higher systolic and diastolic blood pressures, more menstrual irregularities (all p less than 0.01), and higher waist/hip ratios (p less than 0.05). They had higher triglyceride, very-low-density lipoprotein C-III levels and lower high-density lipoprotein cholesterol concentrations (all p less than 0.01). They had lower apolipoprotein A-I/A-II ratios (p less than 0.01). After administration of GnRH analog, androgen and estrogens were suppressed and insulin resistance was unaltered. Insulin correlated with apolipoprotein lipid abnormalities.
CONCLUSION: Lipid and apolipoprotein abnormalities in these hirsute women seem to be associated more with insulin resistance than with endogenous androgens or estrogens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566769     DOI: 10.1016/s0002-9378(11)90605-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.

Authors:  H J Teede; S Hutchison; S Zoungas; C Meyer
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 2.  Polycystic ovarian syndrome: diagnosis and management.

Authors:  Michael T Sheehan
Journal:  Clin Med Res       Date:  2004-02

Review 3.  Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset.

Authors:  L Ibáñez; F de Zegher; N Potau
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

4.  Prediction of metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Fırat Ersan; Esra Arslan; Aytül Çorbacıoğlu Esmer; Serdar Aydın; Asuman Gedikbaşı; Ali Gedikbaşı; Ismet Alkış; Cemal Ark
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

Review 5.  [Insulin resistance in polycystic ovary syndrome].

Authors:  Annika K Schröder; Sascha Tauchert; Olaf Ortmann; Klaus Diedrich; Jürgen M Weiss
Journal:  Wien Klin Wochenschr       Date:  2003-12-15       Impact factor: 1.704

6.  Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity.

Authors:  Antoaneta Gateva; Zdravko Kamenov
Journal:  Obstet Gynecol Int       Date:  2012-01-04

7.  Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.

Authors:  Mark J Prodoehl; Nicholas Hatzirodos; Helen F Irving-Rodgers; Zhen Z Zhao; Jodie N Painter; Theresa E Hickey; Mark A Gibson; William E Rainey; Bruce R Carr; Helen D Mason; Robert J Norman; Grant W Montgomery; Raymond J Rodgers
Journal:  Mol Hum Reprod       Date:  2009-08-19       Impact factor: 4.025

8.  Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: a cross- sectional study.

Authors:  Rong Li; Geng Yu; Dongzi Yang; Shangwei Li; Shulan Lu; Xiaoke Wu; Zhaolian Wei; Xueru Song; Xiuxia Wang; Shuxin Fu; Jie Qiao
Journal:  BMC Endocr Disord       Date:  2014-09-16       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.